[EN] TERTIARY AMIDE OREXIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RÉCEPTEURS D'OREXINES AMIDES TERTIAIRES
申请人:MERCK SHARP & DOHME
公开号:WO2011053522A1
公开(公告)日:2011-05-05
The present invention is directed to tertiary amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
本发明涉及三级酰胺化合物,它们是促进素受体的拮抗剂,并且它们在治疗或预防神经和精神障碍和疾病中具有用处,其中促进素受体参与其中。本发明还涉及包含这些化合物的制药组合物,以及在预防或治疗促进素受体参与的这些疾病中使用这些化合物和组合物。